Pharmacogenetics of Response to GLP1R Agonists — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pharmacogenetics of Response to GLP1R Agonists — Stella

Recruiting

Back to Obesity trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Amish Research Clinic, Lancaster, Pennsylvania

Key details

Phase

Early testing

Sponsor

University of Maryland, Baltimore

Enrollment target

~600 participants

Started

April 2022

Primary completion

November 2026

Age range

18 Years – 89 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov